相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis A case report
Yushiro Endo et al.
MEDICINE (2018)
Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis
Kazuhiro Kurasawa et al.
RHEUMATOLOGY (2018)
A case of anti-MDA5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment
Yamaguchi Koichi et al.
MODERN RHEUMATOLOGY (2017)
Clinical characteristics and change in the antibody titres of patients with anti-MDA5 antibody-positive inflammatory myositis
Yoshiyuki Abe et al.
RHEUMATOLOGY (2017)
Intravenous immunoglobulin contributes to the control of antimelanoma differentiation-associated protein 5 antibody-associated dermatomyositis with palmar violaceous macules/papules
H. Koguchi-Yoshioka et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis
T. Matsushita et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Anti-MDA5 dermatomyositis and progressive interstitial pneumonia
M. G. Silveira et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2016)
Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease
R. Nakashima et al.
LUPUS (2016)
Initial limited three-level thin-section computed tomography scorings predict the prognosis of acute/subacute interstitial pneumonia in patients with dermatomyositis
Takuya Kotani et al.
MODERN RHEUMATOLOGY (2016)
Therapeutic Plasma Exchange in Antisynthetase Syndrome With Severe Interstitial Lung Disease
Bolanle A. Omotoso et al.
JOURNAL OF CLINICAL APHERESIS (2015)
High-dose intravenous immunoglobulin therapy for rapidly progressive interstitial pneumonitis accompanied by anti-melanoma differentiation-associated gene 5 antibody-positive amyopathic dermatomyositis
Kazu Hamada-Ode et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2015)
Basiliximab may improve the survival rate of rapidly progressive interstitial pneumonia in patients with clinically amyopathic dermatomyositis with anti-MDA5 antibody
Jing Zou et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease
Shinji Sato et al.
Modern Rheumatology (2014)
Pre-Treatment Ferritin Level and Alveolar-Arterial Oxygen Gradient Can Predict Mortality Rate Due to Acute/Subacufte Interstitial Pneumonia in Dermatomyositis Treated by Cyclosporine A/Glucocorticosteroid Combination Therapy: A Case Control Study
Kentaro Isoda et al.
PLOS ONE (2014)
Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis
Takahisa Gono et al.
RHEUMATOLOGY (2012)
MDA5/RIG-I and virus recognition
Osamu Takeuchi et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis
S Sato et al.
ARTHRITIS AND RHEUMATISM (2005)
分享论文
